Evee Lopez (@eveelpz) 's Twitter Profile
Evee Lopez

@eveelpz

Pediatric Hematology Oncologist @stjude - Proud 🇪🇨 - runner 🏃‍♀️

ID: 136348112

calendar_today23-04-2010 17:43:25

20,20K Tweet

1,1K Followers

766 Following

Melissa Rose, DO (@kidshematology) 's Twitter Profile Photo

CSVT accounted for 14% of VTE in Kids-DOTT trial, more often in neonates and younger children, with ability to stop anticoagulation at 6 weeks (alternative to 3 months). Dr. Gary Woods Nationwide Children's Fellowship Programs grad presenting at #ASH2023

CSVT accounted for 14% of VTE in Kids-DOTT trial, more often in neonates and younger children, with ability to stop anticoagulation at 6 weeks (alternative to 3 months). Dr. Gary Woods <a href="/NCHforFellows/">Nationwide Children's Fellowship Programs</a> grad presenting at #ASH2023
Nico Gagelmann (@nicogagelmann) 's Twitter Profile Photo

HaploBMT with posttransplant cyclophosphamide for sickle cell disease. Bombs dropped against gene therapy during late breaking #ASH23 and during QnA. Access and affordability is key!

HaploBMT with posttransplant cyclophosphamide for sickle cell disease.

Bombs dropped against gene therapy during late breaking #ASH23 and during QnA.

Access and affordability is key!
ESID (@esidsociety) 's Twitter Profile Photo

📢NEW ESID Juniors live webinar - 21 December (16:00 CET). Registrations are now open for the final Juniors Clinical Cases #webinar of the year, " Two tales of inborn errors of immunity presenting as #lymphoproliferation." Register here 👇 shorturl.at/cyE34

📢NEW ESID Juniors live webinar - 21 December (16:00 CET).

Registrations are now open for the final Juniors Clinical Cases #webinar of the year, " Two tales of inborn errors of immunity presenting as #lymphoproliferation."

Register here 👇
shorturl.at/cyE34
ESID (@esidsociety) 's Twitter Profile Photo

APPLICATIONS ARE OPEN - ESID 2024 SUMMER SCHOOL!!! An exciting opportunity to accelerate your career in #PID and #network with experts and colleagues in the field 👩‍⚕️👨‍⚕️ Apply before 31 January 2024!!! Criteria & submission details available here 👇 esid.org/News-Events/ES…

APPLICATIONS ARE OPEN - ESID 2024 SUMMER SCHOOL!!!

An exciting opportunity to accelerate your career in #PID and #network with experts and colleagues in the field 👩‍⚕️👨‍⚕️

Apply before 31 January 2024!!!

Criteria &amp; submission details available here 👇
esid.org/News-Events/ES…
Transplantation and Cellular Therapy Journal (@astct_journal) 's Twitter Profile Photo

Is blinatumomab — a BiTE single-chain antibody approved for treatment in patients with r/r B-ALL — an ideal strategy to improve patient outcomes? Dr. Franco Locatelli makes a case: ow.ly/lv1u50Qz0Lh

Is blinatumomab — a BiTE single-chain antibody approved for treatment in patients with r/r B-ALL — an ideal strategy to improve patient outcomes? Dr. Franco Locatelli makes a case: ow.ly/lv1u50Qz0Lh
Vijay Sankaran (@bloodgenes) 's Twitter Profile Photo

Why do Latino children have the highest risk for childhood leukemia in the US? We identify one cause for this in a paper out in Cell Genomics today, led by Adam de Smith, Lara Wahlster, Soyoung Elizabeth Jeon, Fulong Yu, Charleston Chiang, & colleagues: cell.com/cell-genomics/…

Why do Latino children have the highest risk for childhood leukemia in the US? We identify one cause for this in a paper out in <a href="/CellGenomics/">Cell Genomics</a> today, led by <a href="/adamdesmith/">Adam de Smith</a>, <a href="/LWahlster/">Lara Wahlster</a>, <a href="/SoYoungJeon_Eli/">Soyoung Elizabeth Jeon</a>, <a href="/fulong_yu/">Fulong Yu</a>, <a href="/CharlestonCWKC/">Charleston Chiang</a>, &amp; colleagues: 
cell.com/cell-genomics/…
Blood Journal (@bloodjournal) 's Twitter Profile Photo

Hydroxyurea reduces infections in children with sickle cell anemia in Uganda ow.ly/oOBq50R8IH1 #clinicaltrialsandobservations #pediatrichematology #redcellsironanderythropoiesis #sicklecelldisease #SCD

Hydroxyurea reduces infections in children with sickle cell anemia in Uganda ow.ly/oOBq50R8IH1 #clinicaltrialsandobservations #pediatrichematology #redcellsironanderythropoiesis #sicklecelldisease #SCD
Blood Journal (@bloodjournal) 's Twitter Profile Photo

Subcutaneous emicizumab administered from birth has the potential to reduce the risk of ICH and joint bleeds before damage occurs. ow.ly/eYnO50R8K4s #clinicaltrialsandobservations #pediatrichematology #thrombosisandhemostasis

Subcutaneous emicizumab administered from birth has the potential to reduce the risk of ICH and joint bleeds before damage occurs. ow.ly/eYnO50R8K4s #clinicaltrialsandobservations #pediatrichematology #thrombosisandhemostasis
NEJM (@nejm) 's Twitter Profile Photo

Of 35 patients with transfusion-dependent β-thalassemia treated with gene-edited autologous hematopoietic stem and progenitor cells, 32 had hemoglobin levels maintained without red-cell transfusions for at least 12 consecutive months. Full study results: nej.md/3xYXrI1

Of 35 patients with transfusion-dependent β-thalassemia treated with gene-edited autologous hematopoietic stem and progenitor cells, 32 had hemoglobin levels maintained without red-cell transfusions for at least 12 consecutive months. Full study results: nej.md/3xYXrI1
Evee Lopez (@eveelpz) 's Twitter Profile Photo

Doing a lit search about “sports in Pediatric Oncology Patients” the few papers I found are from Germany. Where does American stand ? 🤔